Adulsa Therapeutics Corp

Biotechnology company · Berwyn, Pennsylvania, United States

Adulsa Therapeutics Corp is a biotechnology company headquartered in Berwyn, Pennsylvania, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $525,000 sold in a notice filed in 2021.

Profile compiled from public records. Is this your company? Request a correction or update

Adulsa Therapeutics at a glance

Typebiotechnology company
HeadquartersBerwyn, Pennsylvania, United States
Earliest incorporation on record2020
SEC CIK1887934

What does Adulsa Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $525,000 sold (2021).

Frequently asked questions about Adulsa Therapeutics

Where is Adulsa Therapeutics headquartered?

Adulsa Therapeutics Corp is headquartered in Berwyn, Pennsylvania, United States.

What does Adulsa Therapeutics do?

Adulsa Therapeutics Corp is a biotechnology company.

When was Adulsa Therapeutics founded?

The earliest incorporation on record for Adulsa Therapeutics Corp is in 2020, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences

Adulsa Therapeutics: Headquarters, Locations & Company Profile (2026) | BioBridgeX